Latest News and Press Releases

New York, USA, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Epilepsy Market Assessment in the 7MM by 2034 — A Detailed Analysis of Growth Prospects Across Different Types | DelveInsight According to...

Neurona Unveils Phase 3 EPIC Study for NRTX-1001 Cell Therapy in Epilepsy

CORAL GABLES, Fla., Feb. 12, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing,...

CORAL GABLES, Fla., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX) today announced its inclusion in Forbes' esteemed list of America's Most...

Dublin, Jan. 14, 2025 (GLOBE NEWSWIRE) -- The "Tele-epilepsy Market by Epilepsy Type, Patient Type, Component, End User and Region" report has been added to ResearchAndMarkets.com's offering. This...

CORAL GABLES, Fla., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing,...

CBIH has formally filed a petition to have Ms. Alexis Bortell serve as a witness in the upcoming DEA hearing on marijuana rescheduling.

Crossject modifie les termes et conditions des obligations convertibles en actions nouvelles ou remboursables souscrites par Heights Capital Management, Inc. (« Heights ») Dijon, FRANCE, 11 Décembre...

Crossject to amend the Heights Capital Management, Inc. (“Heights”) bonds convertible in new shares or repayable Dijon, FRANCE, December 11, 2024 – 8 a.m. (CET) – Crossject (ISIN: FR0011716265;...

Cannabis Bioscience International Holdings CEO Dante Picazo Addresses Cannabis Reclassification and DEA Hearings